Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 8;14(4):392.
doi: 10.3390/jpm14040392.

Advances in Urinary Diversion: From Cutaneous Ureterostomy to Orthotopic Neobladder Reconstruction-A Comprehensive Review

Affiliations
Review

Advances in Urinary Diversion: From Cutaneous Ureterostomy to Orthotopic Neobladder Reconstruction-A Comprehensive Review

Biagio Barone et al. J Pers Med. .

Abstract

Bladder cancer ranks as the 10th most prevalent cancer globally with an increasing incidence. Radical cystectomy combined with urinary diversion represents the standard treatment for muscle-invasive bladder cancer, offering a range of techniques tailored to patient factors. Overall, urinary diversions are divided into non-continent and continent. Among the first category, cutaneous ureterostomy and ileal conduit represent the most common procedures while in the second category, it could be possible to describe another subclassification which includes ureterosigmoidostomy, continent diversions requiring catheterization and orthotopic voiding pouches and neobladders. In this comprehensive review, urinary diversions are described in their technical aspects, providing a summary of almost all alternatives to urinary diversion post-radical cystectomy.

Keywords: bladder cancer; ileal conduit; orthotopic neobladder; ureterostomy; urinary diversion.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Studer Neobladder.
Figure 2
Figure 2
Hautmann Neobladder.
Figure 3
Figure 3
VIP Neobladder.
Figure 4
Figure 4
Camey Neobladder.
Figure 5
Figure 5
Anatolian Neobladder.
Figure 6
Figure 6
Florin Neobladder.

Similar articles

Cited by

  • Bladder exstrophy: navigating long-term outcomes.
    Town MV, Kim KJ, Vu A, Haffar A, Morganstern BA. Town MV, et al. Transl Androl Urol. 2025 Jun 30;14(6):1797-1806. doi: 10.21037/tau-2024-631. Epub 2025 Jun 26. Transl Androl Urol. 2025. PMID: 40687642 Free PMC article. Review.

References

    1. Saginala K., Barsouk A., Aluru J.S., Rawla P., Padala S.A., Barsouk A. Epidemiology of Bladder Cancer. Med. Sci. 2020;8:15. doi: 10.3390/medsci8010015. - DOI - PMC - PubMed
    1. Jubber I., Ong S., Bukavina L., Black P.C., Compérat E., Kamat A.M., Kiemeney L., Lawrentschuk N., Lerner S.P., Meeks J.J., et al. Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors. Eur. Urol. 2023;84:176–190. doi: 10.1016/j.eururo.2023.03.029. - DOI - PubMed
    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA. Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Halaseh S.A., Halaseh S., Alali Y., Ashour M.E., Alharayzah M.J. A Review of the Etiology and Epidemiology of Bladder Cancer: All You Need To Know. Cureus. 2022;14:e27330. doi: 10.7759/cureus.27330. - DOI - PMC - PubMed
    1. Caballero J.M., Gili J.M., Pereira J.C., Gomáriz A., Castillo C., Martín-Baranera M. Risk Factors Involved in the High Incidence of Bladder Cancer in an Industrialized Area in North-Eastern Spain: A Case–Control Study. J. Clin. Med. 2023;12:728. doi: 10.3390/jcm12020728. - DOI - PMC - PubMed